Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is known as a risk of incident cardiovascular disease (CVD). About 20% of NAFLD occurs in nonobese individuals. However, it remains to be elucidated the association between nonoverweight with NAFLD and a risk of incident CVD. Therefore, we investigated the risk of nonoverweight with NAFLD for incident CVD.We performed a post-hoc analysis of the previous prospective cohort study, in which 1647 Japanese were enrolled. Abdominal ultrasonography was used to diagnose NAFLD. Overweight was defined as body mass index ≥23 kg/m, which is recommended by World Health Organization for Asian. We divided participants into 4 phenotypes by existence of NAFLD and/or overweight. The hazard risks of the 4 phenotypes for incident CVD were calculated by Cox hazard model after adjusting for age, sex, smoking status, exercise, hypertension, hyperglycemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol at baseline examination.Incident proportions of CVD were 0.6% in nonoverweight without NAFLD, 8.8% in nonoverweight with NAFLD, 1.8% in overweight without NAFLD, and 3.3% in overweight with NAFLD. Compared with nonoverweight without NAFLD, the adjusted hazard ratios of incident CVD were 10.4 (95% confidence interval 2.61-44.0, P = .001) in nonoverweight with NAFLD, 1.96 (0.54-7.88, P = .31) in overweight without NAFLD, and 3.14 (0.84-13.2, P = .09) in overweight with NAFLD.Nonoverweight with NAFLD was associated with higher risk of incident CVD. We should pay attention to NAFLD, even in nonoverweight individuals, to prevent further CVD events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., & Tsugane, S. (2006) · Circulation · doi:10.1161/circulationaha.105.581355 · Cited by 557
Mahabadi, A. A., Berg, M. H., Lehmann, N., Kälsch, H., Bauer, M., Kara, K., Dragano, N., Moebus, S., Jöckel, K.-H., Erbel, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.062 · Cited by 529 · cited 12×
“We defined coronary heart disease, ischemic stroke, and cerebral hemorrhage as CVD. Coronary heart disease includes unstable angina, acute myocardial infarction, and silent myocardial infarction, and stable angina pectoris was not included.”
BackgroundInfluential
Research works printed but not linked: 29
- Hashimoto, 2013, Characteristics and diagnosis of NAFLD/NASH, J Gastroenterol Hepatol, 28, 64, 10.1111/jgh.12271 · DOI · Paper page
- Masarone, 2014, Non alcoholic fatty liver: epidemiology and natural history, Rev Recent Clin Trials, 9, 126, 10.2174/1574887109666141216111143 · DOI · Paper page
- Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 · DOI · Paper page
- Federico, 2016, The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction, Eur Rev Med Pharmacol Sci, 20, 4731
- Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193 · DOI · Paper page
- Hamaguchi, 2007, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease, World J Gastroenterol, 13, 1579, 10.3748/wjg.v13.i10.1579 · DOI · Paper page
- Persico, 2017, Non alcoholic fatty liver disease and eNOS dysfunction in humans, BMC Gastroenterol, 17, 35, 10.1186/s12876-017-0592-y · DOI · Paper page
- Deurenberg, 2002, Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship, Obes Rev, 3, 141, 10.1046/j.1467-789X.2002.00065.x · DOI · Paper page
- Liu, 2012, Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese, J Gastroenterol Hepatol, 27, 1555, 10.1111/j.1440-1746.2012.07222.x · DOI · Paper page
- Fukuda, 2016, The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals, Liver Int, 36, 275, 10.1111/liv.12912 · DOI · Paper page
- Di Renzo, 2016, Association of body composition and eating behavior in the normal weight obese syndrome, Eat Weight Disord, 21, 99, 10.1007/s40519-015-0215-y · DOI
- De Lorenzo, 2007, Normal-weight obese syndrome: early inflammation?, Am J Clin Nutr, 85, 40, 10.1093/ajcn/85.1.40 · DOI · Paper page
- Abenavoli, 2016, Body composition and non-alcoholic fatty liver disease, J Lifestyle Med, 6, 47, 10.15280/jlm.2016.6.1.47 · DOI
- Marchesini, 2015, NAFLD incidence and remission: only a matter of weight gain and weight loss?, J Hepatol, 62, 15, 10.1016/j.jhep.2014.10.023 · DOI
- Hashimoto, 2015, The modest alcohol consumption reduces the incidence of fatty liver in men; a population based large scale cohort study, J Gastroenterol Hepatol, 30, 546, 10.1111/jgh.12786 · DOI
- Aaron, 1995, Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents, Am J Epidemiol, 142, 191, 10.1093/oxfordjournals.aje.a117618 · DOI · Paper page
- Hamaguchi, 2007, The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation, Am J Gastroenterol, 102, 2708, 10.1111/j.1572-0241.2007.01526.x · DOI · Paper page
- 2001, Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)., JAMA, 285, 2486, 10.1001/jama.285.19.2486 · DOI · Paper page
- 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies., Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3 · DOI · Paper page
- Hashimoto, 2015, Maintaining metabolically healthy overweight and risk of incident type 2 diabetes or cardiovascular disease, Int J Diabetol Vasc Dis Res, 3, 122
- Younossi, 2012, Nonalcoholic fatty liver disease in lean individuals in the United States, Medicine (Baltimore, 91, 319, 10.1097/MD.0b013e3182779d49 · DOI · Paper page
- Byrne, 2013, Ectopic fat, insulin resistance and non-alcoholic fatty liver disease, Proc Nutr Soc, 72, 412, 10.1017/S0029665113001249 · DOI
- Stefan, 2008, Causes and metabolic consequences of fatty liver, Endocr Rev, 29, 939, 10.1210/er.2008-0009 · DOI · Paper page
- Abenavoli, 2016, Metabolic aspects of adult patients with nonalcoholic fatty liver disease, World J Gastroenterol, 22, 7006, 10.3748/wjg.v22.i31.7006 · DOI · Paper page
- Abenavoli, 2014, Role of adipokines and cytokines in non-alcoholic fatty liver disease, Rev Recent Clin Trials, 9, 134, 10.2174/1574887109666141216102458 · DOI · Paper page
- Taylor, 2015, Normal weight individuals who develop type 2 diabetes: the personal fat threshold, Clin Sci (Lond, 128, 405, 10.1042/CS20140553 · DOI · Paper page
- Hashimoto, 2015, Metabolically healthy obesity and risk of incident CKD, Clin J Am Soc Nephrol, 10, 578, 10.2215/CJN.08980914 · DOI · Paper page
- Rey-López, 2014, The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used, Obes Rev, 15, 781, 10.1111/obr.12198 · DOI · Paper page
- Hernaez, 2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452 · DOI · Paper page
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“In a Japanese cohort, the adjusted hazard ratio for cardiovascular disease was ~10-fold higher in nonobese individuals with NAFLD compared with those without NAFLD (Yoshitaka et al., 2017).”
BackgroundYe, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000153 · Cited by 727
Metadata
- Authors
- Yoshitaka, H., Hamaguchi, M., Kojima, T., Fukuda, T., Ohbora, A., & Fukui, M.
- Venue
- Medicine
- Published
- 2017-05
- Volume
- 96
- Issue
- 18
- Pages
- e6712
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2611448195
- Cited by
- 114
- References
- 4
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. https://app.cochat.ai/papers/10.1097/md.0000000000006712
- The paper
- Yoshitaka, H., Hamaguchi, M., Kojima, T., Fukuda, T., Ohbora, A., & Fukui, M. (2017). Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. Medicine. https://doi.org/10.1097/md.0000000000006712
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.